Association of Coronary Stenosis and Plaque Morphology With Fractional Flow Reserve and Outcomes

Amir Ahmadi1, Gregg W Stone2, Jonathon Leipsic3

  • 1Division of Cardiology, Icahn School of Medicine at Mount Sinai, New York, New York2Division of Cardiology and Radiology, University of British Columbia, Vancouver, Canada.

JAMA Cardiology
|July 21, 2016
PubMed

Insights

Fractional flow reserve (FFR) identifies significant coronary lesions, guiding revascularization decisions. Abnormal FFR may relate to plaque composition, not just stenosis, impacting acute coronary syndrome risk.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Vascular Biology

Background:

  • Obstructive coronary lesions can cause reduced blood flow, assessed by myocardial perfusion imaging or fractional flow reserve (FFR).
  • Abnormal FFR (≤0.80) identifies high-risk lesions for percutaneous coronary intervention, reducing procedures and improving outcomes.
  • FFR predicts ischemia symptoms but its role in predicting acute coronary syndromes (ACS) from plaque rupture is less clear.

Purpose of the Study:

  • To explore the relationship between plaque composition, ischemia, and FFR.
  • To understand why FFR might predict acute coronary syndromes.

Main Methods:

  • Analysis of coronary lesions, luminal dimensions, and myocardial blood flow.
  • Assessment of fractional flow reserve (FFR) during hyperemia-induced vasodilation.
  • Evaluation of atherosclerotic plaque characteristics, including necrotic core size.

Main Results:

  • Large necrotic cores in plaques, irrespective of stenosis, are linked to increased ischemia and lower FFR.
  • The inability of vessels to dilate due to necrotic cores may contribute to ischemia and abnormal FFR.
  • Normal FFR suggests unimpaired vasoregulation and less likelihood of large necrotic cores.

Conclusions:

  • FFR is a valuable tool for assessing hemodynamically significant coronary lesions.
  • Plaque composition, particularly large necrotic cores, may influence FFR and ischemia.
  • Further research is needed to integrate plaque assessment with FFR for optimal treatment decisions in stable coronary artery disease.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
727
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
894
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
384
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
373